type 1 diabetes
Item
type 1 diabetes
boolean
C0011854 (UMLS CUI [1])
fasting c-peptide
Item
fasting c-peptide below lower limit of normal fasting range
boolean
C2208720 (UMLS CUI [1])
duration of diabetes
Item
duration of type 1 diabetes for at least 12 months
boolean
C0872146 (UMLS CUI [1,1])
C0011854 (UMLS CUI [1,2])
current treatment
Item
current treatment: basal - bolus regimen for at least 4 months with intermediate or long-acting insulin once, twice or three times daily as basal insulin and 3-4 premeal insulin aspart or lispro injections
boolean
C0087111 (UMLS CUI [1])
hba1c
Item
hba1c maximum 9.0% (using biorad variant method)
boolean
C0019018 (UMLS CUI [1])
blood glucose
Item
able and willing to perform self-monitoring of blood glucose
boolean
C0202042 (UMLS CUI [1])
basal insulin requirement
Item
basal insulin requirement at least 30% of the total daily insulin dose
boolean
C0650607 (UMLS CUI [1])
BMI
Item
bmi (body mass index) maximum 35 kg/m^2
boolean
C1305855 (UMLS CUI [1])
retinopathy or maculopathy
Item
proliferative retinopathy or maculopathy requiring acute treatment
boolean
C0035309 (UMLS CUI [1])
C0730362 (UMLS CUI [2])
insulin dose
Item
total daily insulin dose above 1.4 iu/kg/day
boolean
C0021641 (UMLS CUI [1])
unawareness of hypoglycaemia
Item
known unawareness of hypoglycaemia
boolean
C0342317 (UMLS CUI [1])
impaired hepatic function
Item
impaired hepatic function
boolean
C0232741 (UMLS CUI [1])
impaired renal function
Item
impaired renal function
boolean
C0232804 (UMLS CUI [1])
cardiac problems
Item
cardiac problems
boolean
C0262402 (UMLS CUI [1])
hypertension
Item
uncontrolled, treated/untreated hypertension
boolean
C0020538 (UMLS CUI [1])
allergy to trial product
Item
known or suspected allergy to trial product or related products
boolean
C0020517 (UMLS CUI [1,1])
C3854006 (UMLS CUI [1,2])